ABSTRACTS SUBMISSIONS

SPONSORIZED BY    

The Southern European Veterinary Conference-SEVC 2026 invites veterinarians to submit abstracts either as COMMUNICATIONS relating to clinical research, both prospective and retrospective, or CASE REPORTS that present new or alternative information of interest to a small animal or exotic animal clinicians.

All accepted abstracts must be presented in poster format during the Congress. Original work only will be accepted.

CHECK OUT THE GUIDE ON HOW TO WRITE SCIENTIFIC COMMUNICATIONS OR CLINICAL CASES HERE. (This information is intended for new researchers presenting their first papers. For more experienced researchers, it can serve as a guide for mentoring people in their research groups or workplaces.)

If you are already registered to the conference and you want to see or send a resume access HERE

• Access the Registration form: HERE
• If you are already registered to the conference ACCESS HERE to submit an Communication 
• Indicate your ID/PASSPORT. You will automatically proceed to step 2, where your personal information will be requested.
• Confirm that you wish to submit a Communication.
• Begin filling out the fields with the details of your Communication. We explain how below. It is not necessary to complete the paper submission process. Once you have registered as a contact author, you can submit the Communication(s)/Clinical Case Study(s) you wish. You can also make any changes you deem appropriate to the submitted text until the abstract submission deadline. Once you finish your work, remember to submit the final version. 
• Register to the Conference.

• LANGUAGE: Abstracts and posters will only be accepted in Spanish or English.
• DEADLINE: Abstracts must be received by June 17, 2026 (papers will be accepted until 11:59 PM on June 17, 2026, Spain time).
• OBJECTIVES: Abstracts must adequately describe the objectives and results so that the quality and originality of the work can be assessed.
• REFERENCES: Do not include any references to the veterinary center in the text. Reviewers should not have any references to the author of the paper. If a reference is made, the paper will be automatically rejected.
• ORIGINAL PAPERS: Papers that have been previously published in journals or at conferences will be rejected.
• AUTHORSHIP CRITERIA: SEVC-AVEPA recommends including as authors only those who have actively participated in the clinical cases or scientific communication, whether in the conception and design, data acquisition and interpretation of results, or in the writing of the text. AVEPA-SEVC understands that when submitting a paper for review, all authors must approve the submitted text. The first author is the one who has worked the most on the study, leaving the last place on the author list for the senior researcher, supervisor, and person responsible for the final review before submission.
• CO-AUTHORS: Each Scientific Communication or Clinical Case may include all existing co-authors, but only one person may be listed as the lead author of the paper for purposes of contact, presentation of the paper, and reduction of the registration fee.
• SUBMISSION: Abstracts must be submitted by completing all the fields enabled in the platform provided for each case. Submission of the paper in any other format will not be accepted. Upon submitting the communication/clinical case, the contact author will automatically receive confirmation of receipt of their paper from the secretary with an assignment code, which will be used to identify their work for any questions they may have. To allow anonymous evaluation of the work, the names of the authors or their institutions must not appear in the submitted abstracts. Otherwise, the submission will be automatically rejected.
• FINAL VERSION: Upon submitting your communication as a final version (not in draft status), the lead author will automatically receive confirmation of receipt of the paper from the secretary with an assignment code, which will be used to identify your work for any questions they may have. If you do not receive a confirmation email, it means the paper has NOT been successfully submitted.
• EVALUATION: Once the deadline has passed, the evaluation process will begin, and modifications will not be accepted (unless requested by the reviewers), nor will new free papers/clinical cases be accepted.
• CONFERENCE REGISTRATION: The lead author or one of the authors may and must register for the conference. A special registration rate will be offered only to one of the authors of the paper.

The following sections must be submitted: (depending on whether it is a Scientific Communication or a Clinical Case; in both cases, the maximum word count is 1,250, including all sections, except for the references).

SCIENTIFIC COMMUNICATIONS:

• Short Abstract: Maximum 250 words. 
• Communication: The maximum word limit allowed will be 1,000 words
• Objective of the Study: A brief introduction to the research purpose using relevant and current literature. This section concludes by stating the objectives of the study.
• Materials and Methods: With a description of the procedures, including the statistical analysis.
  Results: Describe your most important results objectively. Expressions such as "the results will be presented..." cannot be used.
• Conclusions: Explain the results in the context of the research and hypotheses, as well as their relevance, briefly describing why this research study is novel to the scientific community. Any statement made in the study that is not derived from the results should be referenced. This may include future stages of the research.
• References: (no limits of references) Any statement made in the article that is not derived from the results should be accompanied by a corresponding bibliographic citation. These references should be listed at the end of the article according to their appearance in the text (not alphabetically), and should be numbered consecutively based on their order of appearance. These numbers should be included in the text.
  Reference Examples:
  Journals:
  Name all authors if there are fewer than six. If there are more, name the first three and then add et al.
  4. De Risio L, Thomas WB, Sharp NJH: Degenerative lumbosacral stenosis. Vet Clin North Am Small Anim Pract 2000; 30(1):111-132.
  Books:
  12. Prata RG: Cauda equina syndrome. In Slatter DH (ed): Textbook of Small Animal Surgery, Philadelphia, WB Saunders, 1993; 1094-1104.
• Images: You may add as many images and tables as you deem appropriate to each section within the text.

CLINICAL CASES:

• Short Abstract: Maximum 250 words.
• Clinical Case: The maximum word limit allowed will be 1,000 words
• Introduction: Briefly introduce the pathology presented in the clinical case.
• Clinical Case Description: Describe the case using medical terms (information such as the patient's name should not be included in a scientific text).
• Discussion and Conclusions: Explain the findings and their relevance, briefly describing why the clinical case is novel to the scientific community.
• References: (no limits) Any statement made in the article that is not based on the results of the article must be accompanied by a corresponding bibliographic citation. These references should be listed at the end of the article according to their appearance in the text (not alphabetically). These references should be numbered consecutively based on their order of appearance. These numbers should be included in the text.
  Examples of References:
  Journals:
  Name all authors if there are fewer than six. If there are more, name the first three and then add et al.
  4. De Risio L, Thomas WB, Sharp NJH: Degenerative lumbosacral stenosis. Vet Clin North Am Small Anim Pract 2000; 30(1):111-132.
  Books:
  12. Prata RG: Cauda equina syndrome. In Slatter DH (ed): Textbook of Small Animal Surgery, Philadelphia, WB Saunders, 1993; 1094-1104.

Once the summaries have been received, they will be evaluated by members of the AVEPA Scientific Committee or other expert evaluators using only the assignment code of the essay; never with the name and personal details of the author. Once the summaries have been evaluated, the authors will be informed as to whether or not their essay has been accepted.

To allow anonymous evaluation of the work, the names of the authors or their institutions must not appear in the submitted abstracts. Otherwise, the submission will be automatically rejected.

In some cases, or when considered necessary, authors will be asked to make modifications or corrections to some aspects of their poster. This means that the newly revised poster will have to be resubmitted, with new deadlines to be specified to each author. Summaries received after this new date will not be included in the congress programme.

Once an essay has been accepted its main author can and indeed must register for the complete SEVC Congress conference fee before 30  September 2026. Anyone whose open topic presentation has been accepted and who have not registered by the above-mentioned date will lose the option to present their work.

Posters must be submitted in two formats: 

• DIGITAL – Authors are required to upload their poster in PNG format for publication on the conference website. Detailed instructions on how to submit the file will be sent by email.
  
• PRINTED – Authors must also bring a printed version of the poster, sized 90 cm wide × 160 cm high. This printed version must be identical to the digital file submitted online.
  Posters must be placed in the designated Poster Area at the conference venue. Additional setup instructions will be provided via email.

POSTERS PRESENTATION
On Friday, November 20th in the afternoon, all authors are requested to be present in the Poster Area to answer questions from attendees.
During this session, the Scientific Committee will announce the Poster Awards.

Accepted abstracts will be independently and blindly evaluated by two reviewers, who will assess:

• Originality of the topic
  
• Practical application
  
• Scientific rigor
  

Subsequently, the three papers with the highest score in each category will be evaluated by a Jury, which will decide which abstracts will receive the award for the best paper, according to the following categories:

•  ARTUR FONT Award for Best Scientific Communication
• Best Clinical Case Award
• Young Veterinarian Incentive Award (first author up to 29 years of age)

The Jury will be composed of three renowned veterinarians, whose membership will be renewed annually and who will be invited by the AVEPA Scientific Committee. The Scientific Communications Coordinators will not be part of the Jury.

The Scientific Committee reserves the right to declare any category void and to award additional prizes.

The prize will consist of €500 in cash and a certificate of recognition. The authors of the winning papers will be notified prior to the start of the Congress.

All accepted abstracts will be published in image format on the conference platform.

The Scientific Committee reserves the right to publish the abstracts in AVEPA's official journal, "Clínica Veterinaria de Pequeños Animales," or on the AVEPA website, following their presentation at the conference.The coordinator of the journal "Clínica Veterinaria de Pequeños Animales" will select the papers accepted by SEVC for possible publication in the journal. AVEPA will contact the authors to request, if they are interested, that they expand the text for review and publication in the journal.